论文部分内容阅读
对20例可手术乳腺癌病人进行改良根治术和传统根治术腋淋巴结清扫程度的自身对比研究。结果表明,15例乳腺癌临床Ⅰ、Ⅱ期中有3例作改良根治术后残留淋巴结4枚,但无癌转移;临床ⅢA期病人5例中有3例作改良根治术后残留淋巴结5枚,其中1例2枚淋巴结中有癌转移,但其改良根治术标本中4枚淋巴结有癌转移;改良根治术腋淋巴结残留率为30%(6/20)。提示对临床Ⅰ、Ⅱ期乳腺癌病人采用改良根治术作为标准术式是可行的。
A self-contrast study of 20 cases of operable breast cancer patients undergoing modified radical mastectomy and conventional radical axillary lymph node dissection. The results showed that of the 15 patients with stage I and II breast cancer, 3 had residual lymph nodes after modified radical resection, but no cancer metastasis; 3 of 5 patients with stage IIIA patients had 5 residual lymph nodes after modified radical surgery. One of the 2 lymph nodes had cancer metastasis, but 4 lymph nodes in the modified radical mastectomy specimen had cancer metastasis; the residual lymph node was 30% (6/20) in the modified radical mastectomy. It is feasible to use modified radical mastectomy as a standard surgical procedure for stage I and stage II breast cancer patients.